Malignant T Cell Amplified Sequence 1 (MCTS1) Peptid
MCTS1
Wirt: Synthetic
BP, Imm
Produktnummer ABIN2816021
Kurzübersicht für Malignant T Cell Amplified Sequence 1 (MCTS1) Peptid (ABIN2816021)
Target
MCTS1
(Malignant T Cell Amplified Sequence 1 (MCTS1))
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunogen (Imm)
-
-
Sequenz
- DEKENVSNCI QLKTS
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
-
Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at ambient temperature, store at -20°C.
-
-
- MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
Target
-
Sie sind hier:
